We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quanta Biosciences and IDT Partner to Develop and Produce microRNA PCR
Product News

Quanta Biosciences and IDT Partner to Develop and Produce microRNA PCR

Quanta Biosciences and IDT Partner to Develop and Produce microRNA PCR
Product News

Quanta Biosciences and IDT Partner to Develop and Produce microRNA PCR


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Quanta Biosciences and IDT Partner to Develop and Produce microRNA PCR"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Quanta Biosciences (Gaithersburg, MD) has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies (Coralville, IA) to custom manufacture them.

MicroRNAs have been shown to play a key role in cancer as well as many biological processes including neurological and cardiac function. Quanta’s portfolio of microRNA products will allow scientists to accurately detect and profile mature miRNA (miR) sequences.

Early access customers have deployed Quanta’s microRNA assays for toxicology screening during drug development, and quality control of stem-cell pluripotency and differentiation. IDT, the Custom Biology Company and world leader in oligonucleotide synthesis, will produce the assays and supply them through an online catalog directly to Quanta’s customers.
Advertisement